Imprivata OneSign Streamlines Access to Siemens MedSeries4 and Clinical Applications; Improves Clinical Workflow and Secures Patient Data
Company Supports Needs of Federal Government Agencies with Strategic Partnerships, Full FIPS 140-2 Compliance and Appointment of Industry Veteran
LEXINGTON, Mass.—August 3, 2010—Imprivata®, Inc., the company that simplifies and secures user access, today announced that it is bringing its expertise to the government market and that its new OneSign® 4.5 product release fully supports FIPS 140-2 compliance. The move comes as a result of the strong demand for single sign-on (SSO) and strong authentication at government agencies and organizations.
Prior to the COVID-19 pandemic, healthcare organizations were already implementing shared mobile devices in both inpatient and outpatient settings to improve care quality and the patient experience. However, the current emergency has shortened the timeline of deploying these shared devices in hospitals, presenting acquisition, security, and device management challenges.
Seamless Integration of Imprivata OneSign and VMware View Delivers Complete Solution for Fast and Secure Access in Virtual Desktop Environments
Fast, convenient multifactor authentication improves security for telehealth workflows while enabling DEA-compliant electronic prescribing of controlled substances to eliminate paper prescriptions
New Features Solve Workflow and Security Challenges in Windows 7 Environment
OneSign Single Sign-On and Authentication Management Streamline Access to McKesson, MEDITECH and Healthland EMR Across Medical Center and its Branch Hospitals
OneSign's support for broad range of biometric devices for strong authentication earns distinction for balancing user productivity with IT security